KPX Lifescience.Co.Ltd (114450) — Cash Flow-to-Debt Ratio
KPX Lifescience.Co.Ltd (114450) has a Cash Flow-to-Debt Ratio of 0.22x as of September 2025, meaning its operating cash flow of ₩3.33 Billion could theoretically repay 0% of its total liabilities (₩15.22 Billion) in one year. Explore KPX Lifescience.Co.Ltd (114450) long-term investment share to see how much of total assets are deployed in long-term investments.
CF-to-Debt Ratio
Operating Cash Flow
Total Liabilities
Data as of
KPX Lifescience.Co.Ltd Cash Flow-to-Debt Ratio (2014–2024)
Historical debt coverage capacity for KPX Lifescience.Co.Ltd across 11 annual periods. Also explore 114450 total asset value for the complete picture of this company's asset base.
Annual Cash Flow-to-Debt Ratio for KPX Lifescience.Co.Ltd (2014–2024)
Year-by-year debt coverage analysis for KPX Lifescience.Co.Ltd. For market capitalisation and broader financial context, see KPX Lifescience.Co.Ltd (114450) market capitalisation.
| Year | CF-to-Debt Ratio | Operating CF (KRW) | Total Liabilities | YoY Change |
|---|---|---|---|---|
| 2024 | 0.06x | ₩525.49 Million | ₩9.22 Billion | ▲ +21.2% |
| 2023 | 0.05x | ₩370.02 Million | ₩7.87 Billion | ▲ +110.1% |
| 2022 | -0.46x | ₩-4.55 Billion | ₩9.79 Billion | ▼ -1292.0% |
| 2021 | 0.04x | ₩611.38 Million | ₩15.68 Billion | ▼ -76.5% |
| 2020 | 0.17x | ₩1.90 Billion | ₩11.48 Billion | ▼ -54.9% |
| 2019 | 0.37x | ₩4.24 Billion | ₩11.54 Billion | ▼ -29.8% |
| 2018 | 0.52x | ₩5.38 Billion | ₩10.26 Billion | ▲ +0.3% |
| 2017 | 0.52x | ₩5.68 Billion | ₩10.87 Billion | ▲ +13.8% |
| 2016 | 0.46x | ₩7.07 Billion | ₩15.39 Billion | ▼ -16.2% |
| 2015 | 0.55x | ₩5.62 Billion | ₩10.25 Billion | ▲ +99.9% |
| 2014 | 0.27x | ₩4.09 Billion | ₩14.90 Billion | — |